Localization of Jacobsen Syndrome Breakpoints on a 40-Mb Physical Map of Distal Chromosome 11q

  1. Alan Tunnacliffe1,6,7,8,
  2. Christopher Jones2,6,
  3. Denis Le Paslier3,
  4. Roger Todd2,
  5. Dora Cherif3,
  6. Michelle Birdsall4,
  7. Louise Devenish4,
  8. Cherine Yousry5,
  9. Finbarr E. Cotter2, and
  10. Michael R. James3,4,5,8
  1. 1Anglia Research Foundation, Anglia Polytechnic University, Cambridge CB1 1PT, UK; 2Institute of Child Health, London WC1N 1EH, UK; 3Centre d’Étude du Polymorphism Humain (CEPH), Paris 75011, France; 4Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK; 5Institut National de la Santé et de la Recherche Médicale (INSERM) U358, Hôpital St. Louis, Paris 75011, France

Abstract

Jacobsen syndrome is a haploinsufficiency disorder caused, most frequently by terminal deletion of part of the long arm of chromosome 11, with breakpoints in 11q23.3–11q24.2. Inheritance of an expanded p(CCG)n trinucleotide repeat at the folate-sensitive fragile site FRA11B has been implicated in the generation of the chromosome breakpoint in several Jacobsen syndrome patients. The majority of such breakpoints, however, map distal to this fragile site and are not linked with its expression. To characterize these distal breakpoints and ultimately to further investigate the mechanisms of chromosome breakage, a 40-Mb YAC contig covering the distal long arm of chromosome 11 was assembled. The utility of the YAC contig was demonstrated in three ways: (1) by rapidly mapping the breakpoints from two new Jacobsen syndrome patients using FISH; (2) by demonstrating conversion to high resolution PAC contigs after direct screening of PAC library filters with a YAC clone containing a Jacobsen syndrome breakpoint; and (3) by placing 23 Jacobsen syndrome breakpoints on the physical map. This analysis has suggested the existence of at least two new Jacobsen syndrome breakpoint cluster regions in distal chromosome 11.

Footnotes

  • 6 These authors contributed equally to this work.

  • 7 Present address: Institute of Biotechnology, University of Cambridge, Cambridge CB2 1QT, UK.

  • 8 Corresponding authors.

  • E-MAIL at10004{at}biotech.cam.ac.uk; FAX 44-1223-334162.

  • E-MAIL james{at}well.ox.ac.uk; FAX 44-1865-742196.

    • Received October 5, 1998.
    • Accepted November 30, 1998.
| Table of Contents

Preprint Server